Etiology and management of fulminant hepatic failure

[1]  H. Isoniemi,et al.  Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation—12 years experience in the nordic countries , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  K. Dalhoff,et al.  Serum phosphate is an early predictor of outcome in severe acetaminophen‐induced hepatotoxicity , 2002, Hepatology.

[3]  N. Donaldson,et al.  Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study , 2002, The Lancet.

[4]  D. Samuel,et al.  Auxiliary Partial Orthotopic Versus Standard Orthotopic Whole Liver Transplantation for Acute Liver Failure: A Reappraisal From a Single Center by a Case-Control Study , 2001, Annals of surgery.

[5]  H. Isoniemi,et al.  Fulminant hepatic failure — outcome after listing for highly urgent liver transplantation — impact of AB0 blood type , 2001 .

[6]  P. Ott,et al.  Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure , 2001, American Journal of Gastroenterology.

[7]  R. Cortesini,et al.  Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. , 2001, Transplantation proceedings.

[8]  C. Nilsson,et al.  Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. , 2001, Journal of hepatology.

[9]  P. Laterre,et al.  An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the HepatAssist (R) bioartificial liver support system for the treatment of fulminant hepatic failure. , 2001 .

[10]  Roger Williams,et al.  The systemic inflammatory response syndrome in acute liver failure , 2000, Hepatology.

[11]  J. Wendon,et al.  Subclinical Seizure Activity and Prophylactic Phenytoin Infusion in Acute Liver Failure: A Controlled Clinical Trial , 2000, Hepatology.

[12]  S. Vento,et al.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C , 2000, Journal of viral hepatitis.

[13]  M. Sakaguchi,et al.  Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. , 2000, Science.

[14]  L. Mcgavran,et al.  Hepatocyte transplantation in acute liver failure , 2000, Liver transplantation.

[15]  S. Kawasaki,et al.  Living‐related liver transplantation for patients with fulminant and subfulminant hepatic failure , 1999, Hepatology.

[16]  Alistair Lee,et al.  Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure , 1999, The Lancet.

[17]  Y. Liaw,et al.  Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure , 1999, Journal of gastroenterology and hepatology.

[18]  K. Boudjema,et al.  Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. , 1999, Journal of hepatology.

[19]  P. Ott,et al.  Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration , 1999, Hepatology.

[20]  T. Drewniak,et al.  Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. , 1999, Transplantation proceedings.

[21]  K. Boudjema,et al.  Auxiliary versus orthotopic liver transplantation for acute liver failure , 1999 .

[22]  M. G. Peters,et al.  Etiology and outcome for 295 patients with acute liver failure in the United States. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  A. Sanyal,et al.  Treatment of fulminant hepatic failure with intravenous prostaglandin E1. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  P. Hopton,et al.  The effect of N‐acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure , 1998, Hepatology.

[25]  T. Ferraro,et al.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. , 1998, The New England journal of medicine.

[26]  F. Larsen,et al.  Indomethacin normalizes intracranial pressure in acute liver failure: A twenty‐three‐year‐old woman treated with indomethacin , 1997, Hepatology.

[27]  J. Clemmesen,et al.  Indomethacin normalizes intracranial pressure in acute liver failure: A twenty‐three‐year‐old woman treated with indomethacin , 1997 .

[28]  R. Fisher,et al.  Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. , 1997, Transplantation.

[29]  Roger Williams,et al.  Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure , 1996, Hepatology.

[30]  A. Demetriou,et al.  Clinical Experience with a Porcine Hepatocyte-Based Liver Support System , 1996, The International journal of artificial organs.

[31]  B. Shaw,et al.  The American Experience with Transplantation for Acute Liver Failure , 1996, Seminars in liver disease.

[32]  R. Williams,et al.  Classification, Etiology, and Considerations of Outcome in Acute Liver Failure , 1996, Seminars in liver disease.

[33]  J. Moran,et al.  N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. , 1996, Critical care medicine.

[34]  V. Sreenivas,et al.  Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome , 1996, Hepatology.

[35]  J. Hoofnagle,et al.  Fulminant Hepatic Failure : Summary of a Workshop , 2017 .

[36]  J. Wendon,et al.  Indications for orthotopic liver transplantation in fulminant liver failure , 1994, Hepatology.

[37]  K. Detre,et al.  Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. , 1994, Clinical transplantation.

[38]  H. Okamoto,et al.  Contribution of hepatitis C virus to non‐A, non‐B fulminant hepatitis in Japan , 1994, Hepatology.

[39]  T. Starzl,et al.  Liver Transplantation for Fulminant Hepatic Failure , 1985, Seminars in liver disease.

[40]  M. Navasa,et al.  Liver transplantation for acute liver failure: analysis of applicability. , 1993, Gastroenterology.

[41]  Roger Williams,et al.  Acute liver failure: redefining the syndromes , 1993, The Lancet.

[42]  N. Rolando,et al.  Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure , 1993, Hepatology.

[43]  A. Blei,et al.  Complications of intracranial pressure monitoring in fulminant hepatic failure , 1993, The Lancet.

[44]  D. Samuel,et al.  Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. , 1993, Journal of hepatology.

[45]  J. Bernuau.  Selection for emergency liver transplantation. , 1993, Journal of hepatology.

[46]  L. Ferrell,et al.  Hepatitis B virus and apparent fulminant non-A, non-B hepatitis , 1992, The Lancet.

[47]  J. Llach,et al.  Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. , 1992, Journal of hepatology.

[48]  G. Alexander,et al.  Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. , 1991, The New England journal of medicine.

[49]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[50]  R Williams,et al.  Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.

[51]  D. Ganger,et al.  Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization. , 1989, Gastroenterology.

[52]  A. Gimson,et al.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. , 1988, Gastroenterology.

[53]  B. Yvonnet,et al.  Multivariate analysis of prognostic factors in fulminant hepatitis B , 1986, Hepatology.

[54]  J. Bernuau,et al.  Fulminant and Subfulminant Liver Failure: Definitions and Causes , 1986, Seminars in liver disease.

[55]  D. V. van Thiel,et al.  Liver transplantation for fulminant hepatic failure. , 1985, Seminars in liver disease.

[56]  C. S. Davidson,et al.  The management of fulminant hepatic failure. , 1970, Progress in liver diseases.